{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:45:04Z","timestamp":1791254704436,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.euroneuro.2020.12.008","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T19:23:31Z","timestamp":1610133811000},"page":"139-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Factors associated with laxative use in schizophrenia patients treated with second-generation antipsychotics"],"prefix":"10.1016","volume":"43","author":[{"given":"Ching-Hua","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Yu","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chi","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Chua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2020.12.008_bib0001","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"27","year":"2004","journal-title":"Diabetes Care."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0002","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR","year":"2000"},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0003","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","year":"2013"},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0004","series-title":"The American Psychiatric Association Practice Guideline for the Treatment of Patients with Schizophrenia","year":"2021"},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0005","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/2045125315591917","article-title":"Factors predicting use of laxatives in outpatients stabilized on clozapine","volume":"5","author":"Bailey","year":"2015","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0006","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.jcp.0000185423.15891.02","article-title":"Sex differences in the subjective tolerability of antipsychotic drugs","volume":"25","author":"Barbui","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0007","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.schres.2006.09.025","article-title":"Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study","volume":"90","author":"Bobes","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0008","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11096-006-9063-1","article-title":"Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics-a European study","volume":"29","author":"Broekema","year":"2007","journal-title":"Pharm. World Sci."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0009","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/JCP.0000000000001090","article-title":"Is antipsychotic Treatment associated with risk of pneumonia in people with serious mental illness?: The roles of severity of psychiatric symptoms and global functioning","volume":"39","author":"Chan","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/JCP.0000000000000623","article-title":"Time to discontinuation of second-generation antipsychotics versus haloperidol and sulpiride in people with schizophrenia: a naturalistic, comparative study","volume":"37","author":"Chan","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0011","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.schres.2017.10.024","article-title":"Risk of gastrointestinal Hypomotility in schizophrenia and schizoaffective disorder treated with antipsychotics: a retrospective cohort study","volume":"195","author":"Chen","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0012","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.schres.2006.07.011","article-title":"A model of anticholinergic activity of atypical antipsychotic medications","volume":"88","author":"Chew","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0013","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11938-014-0025-8","article-title":"Constipation in adults: diagnosis and management","volume":"12","author":"Costilla","year":"2014","journal-title":"Curr. Treat. Options Gastroenterol."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0014","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-230X-11-17","article-title":"Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study","volume":"11","author":"De Hert","year":"2011","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.eurpsy.2010.03.003","article-title":"Second-generation antipsychotics and constipation: a review of the literature","volume":"26","author":"De Hert","year":"2011","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0016","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00019053-200523050-00006","article-title":"The health-related quality of life and economic burden of constipation","volume":"23","author":"Dennison","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0017","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1177\/0269881112447988","article-title":"Anticholinergics in the era of atypical antipsychotics: short-term or long-term treatment?","volume":"26","author":"Desmarais","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0019","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0004867416641195","article-title":"Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders","volume":"50","author":"Galletly","year":"2016","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0020","series-title":"Reading and Understanding Multivariate Statistics","author":"Grimm","year":"1995"},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0021","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1572-0241.2004.04114.x","article-title":"Epidemiology of constipation in North America: a systematic review","volume":"99","author":"Higgins","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186768","article-title":"Risk factors for readmission in schizophrenia patients following involuntary admission","volume":"12","author":"Hung","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0023","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11126-007-9046-y","article-title":"Reinstitutionalization following psychiatric discharge among VA patients with serious mental illness: a national longitudinal study","volume":"78","author":"Irmiter","year":"2007","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0024","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.genhosppsych.2013.06.007","article-title":"Oversight of constipation in inpatients with schizophrenia: a cross-sectional study","volume":"35","author":"Koizumi","year":"2013","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0025","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/schbul\/sbu001","article-title":"Dose equivalents for second-generation antipsychotics: the minimum effective dose method","volume":"40","author":"Leucht","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0026","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/ijnp\/pyz035","article-title":"Time to Rehospitalization in Patients With Schizophrenia Receiving Long-Acting Injectable Antipsychotics or Oral Antipsychotics","volume":"22","author":"Lin","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0027","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jagp.2019.08.005","article-title":"A comparison of long-acting injectable antipsychotics with oral antipsychotics on time to rehospitalization within 1 year of discharge in elderly patients with schizophrenia","volume":"28","author":"Lin","year":"2020","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0028","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1053\/gast.2000.20392","article-title":"AGA technical review on constipation. American Gastroenterological Association","volume":"119","author":"Locke","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0029","series-title":"Regression Models for Categorical and Limited Dependent Variables","author":"Long","year":"1997"},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0030","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2165\/00002018-199614050-00003","article-title":"A risk-benefit assessment of sulpiride in the treatment of schizophrenia","volume":"14","author":"Mauri","year":"1996","journal-title":"Drug Saf."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0031","doi-asserted-by":"crossref","first-page":"A","DOI":"10.1016\/S0016-5085(08)62468-3","article-title":"Constipation in patients with schizophrenia: a systematic review of antipsychotic trials comparing clozapine","volume":"134","author":"Meek","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0034","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.euroneuro.2009.03.002","article-title":"Increased use of antibiotics in patients treated with clozapine","volume":"19","author":"Nielsen","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0035","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1600-0447.2010.01576.x","article-title":"10-year trends in the treatment and outcomes of patients with first-episode schizophrenia","volume":"122","author":"Nielsen","year":"2010","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0036","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/schbul\/sbq137","article-title":"Risk factors for ileus in patients with schizophrenia","volume":"38","author":"Nielsen","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0037","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/YIC.0b013e328303ac75","article-title":"Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages?","volume":"23","author":"Nose","year":"2008","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0038","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007811","article-title":"Sulpiride versus placebo for schizophrenia","author":"Omori","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0039","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/JCP.0b013e31819a91f1","article-title":"Systematic overview of Cochrane reviews for anticholinergic effects of antipsychotic drugs","volume":"29","author":"Ozbilen","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0040","series-title":"Thousand Oaks","article-title":"Logistic regression: a primer","author":"Pampel","year":"2000"},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0041","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-230X-8-5","article-title":"Epidemiology of constipation in Europe and Oceania: a systematic review","volume":"8","author":"Peppas","year":"2008","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0043","series-title":"Gastrointestinal Pharmacology","first-page":"59","article-title":"Constipation: pathophysiology and current therapeutic approaches","author":"Sharma","year":"2016"},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0044","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3390\/ijms17060863","article-title":"Prevalence and predictors of clozapine-associated constipation: a systematic review and meta-analysis","volume":"17","author":"Shirazi","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12888-016-1172-3","article-title":"Psychiatric readmissions and their association with physical comorbidity: a systematic literature review","volume":"17","author":"Sprah","year":"2017","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0046","unstructured":"Stahl S.M. (2014) Stahl's essential psychopharmacology: prescriber's guide."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0047","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1111\/j.1572-0241.1999.01642.x","article-title":"Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features","volume":"94","author":"Stewart","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0048","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1572-0241.2003.07465.x","article-title":"Risk factors for chronic constipation based on a general practice sample","volume":"98","author":"Talley","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0050","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/08039488.2016.1217044","article-title":"Dyspepsia and constipation in patients with schizophrenia spectrum disorders","volume":"71","author":"Virtanen","year":"2017","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0051","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/WON.0000000000000632","article-title":"Chronic constipation in the community: a national survey of Australian adults","volume":"47","author":"Werth","year":"2020","journal-title":"J. Wound Ostomy Continence Nurs."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0052","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1532-5415.1989.tb02638.x","article-title":"Constipation in the elderly living at home. Definition, prevalence, and relationship to lifestyle and health status","volume":"37","author":"Whitehead","year":"1989","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.euroneuro.2020.12.008_bib0053","series-title":"WHO Col Laborating Centre for Drug Statistic Methodology: Guidelines for ATC Classification and DDD Assignment","year":"2009"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20309913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20309913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:57:06Z","timestamp":1760378226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X20309913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":48,"alternative-id":["S0924977X20309913"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.12.008","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with laxative use in schizophrenia patients treated with second-generation antipsychotics","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}